Reviparin is an antithrombotic in the heparin group.
External links
- MeSH reviparin
- Yusuf S, Mehta SR, Xie C, et al. (2005). "Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation". JAMA 293 (4): 427–35. doi:10.1001/jama.293.4.427. PMID 15671427.
v · d · Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) |
|
Antiplatelet drugs |
|
|
Anticoagulants |
|
|
|
Factor Xa inhibitors
(with some II inhibition)
|
|
low molecular weight heparin (Bemiparin, Certoparin, Dalteparin, Enoxaparin, Nadroparin, Parnaparin, Reviparin, Tinzaparin)
oligosaccharides (Fondaparinux, Idraparinux)
heparinoid ( Danaparoid, Sulodexide, Dermatan sulfate)
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Thrombolytic drugs/
fibrinolytics |
|
|
Non-medicinal |
|
|
|
|
|
|